| Similar Articles |
|---|
 |
American Family Physician
February 15, 2006 |
Psoriasis: What You Should Know A patient information guide: What is psoriasis... Who gets it and why?... How do I know if I have psoriasis?... How is psoriasis treated?... What can I expect?...   |
AskMen.com
Dustin Driver |
Common Skin Disorders The following skin afflictions are usually embarrassing and sometimes very serious. Thankfully, with a little help from your doctor, they can be treated and managed. |
American Family Physician
December 15, 2006 |
Tips for Using Medicines Wisely A patient guide and suggestions for safe medicine use. |
Managed Care
October 2004
Thomas Morrow |
Evaluating New Therapies for Psoriasis Along with traditional systemic therapies, the American Academy of Dermatology recommends four biologic agents as first-line treatment for psoriasis patients who are candidates for systemic therapy. |
American Family Physician
September 1, 2006 |
Getting Your Child to Take Medicine What to do if you child won't take his/her medicine. |
American Family Physician
February 15, 2006
Luba & Stulberg |
Chronic Plaque Psoriasis Patients and physicians should understand that psoriasis is a chronic disease without a cure, and that it is important to have realistic expectations of treatment. Treatment should focus on improvement, not disappearance, of lesions. |
Managed Care
June 2003
Thomas Morrow |
The 'Heartbreak of Psoriasis' Has Met Its Match! New therapies that manipulate the immune system offer hope to patients and pose challenges to managed care. |
American Family Physician
July 15, 2000 |
Men Who Care About Their Skin Protect It More and more men are using sun protection while they work and play outdoors. They know that skin cancer is a threat, but it's a threat they can do something about. If you protect your skin from the sun, your chance of getting skin cancer will be lower.... |
Managed Care
December 2003
David M. Pariser |
Treating Psoriasis Patients With Biologic Agents Improved outcomes with new biologic agents are prompting physicians to integrate them into therapy for psoriasis patients. |
Managed Care
May 2006
Thomas Morrow |
Cost Effective Psoriasis Treatment May Demand Creative Coverage Rules While biologic agents can be costly, a new formulation of an old treatment can mean inexpensive and effective relief. |
The Motley Fool
February 10, 2004
David Nierengarten |
The Psoriasis Wars The pharma heavies are battling for the chronic skin disease's market. |
The Motley Fool
October 8, 2010
Brian Orelli |
Pfizer's Rash (of Bad News) Is Over Data from Pfizer's phase 2 trial testing tasocitinib against psoriasis, a painful autoimmune skin disease, looks promising even given its small size. |
The Motley Fool
April 8, 2005
David Nierengarten |
The Psoriasis Wars Continue Biogen-Idec hopes its new drug will conquer the lucrative psoriasis market. Investors should consider taking a second look at the company's prospects. |
The Motley Fool
October 4, 2007
Brian Orelli |
Stopping the Inflammation Johnson & Johnson subsidiary Centocor announces positive phase 3 data for its psoriasis drug. Given the strong results from the trial, the company plans to file a marketing application for the drug by the end of the year. |
The Motley Fool
February 23, 2005
Brian Gorman |
Amgen Gets Disciplined Direct-to-consumer advertising may be a non-starter for Amgen and other biotech companies. |
